Review articleLipoprotein (a) : structure, properties and possible involvement in thrombogenesis and atherogenesis
References (109)
- et al.
Lp(a) lipoprotein: relationship to sinking pre-B lipoprotein, hyperlipoproteinaemia, and apolipoprotein B
Metabolism
(1975) - et al.
A study of methods of identification and estimation of Lp(a) lipoprotein and of its significance in health, hyperlipidaemia and atherosclerosis
Atherosclerosis
(1974) - et al.
Lipoprotein (a) and plasminogen are immunochemically related
Biochim. Biophys. Acta
(1988) - et al.
Human plasma lipoprotein (a): structural properties
J. Biol. Chem.
(1983) - et al.
Protein composition of Lp(a) lipoprotein from human plasma
FEBS Lett.
(1983) - et al.
Heterogeneity of human plasma protein lipoprotein(a)
J. Biol. Chem.
(1984) - et al.
The association between serum Lp(a) concentration and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels
Atherosclerosis
(1986) - et al.
Apolipoprotein (a), AI, and B and parental history in men with early onset ischaemic heart disease
Lancet
(1988) - et al.
Genetic linkage between lipoprotein (a) phenotype and cDNA polymorphism in the plasminogen gene
Genomics
(1988) - et al.
Lipoprotein (a) is the major apo B-containing lipoprotein in the plasma of a hibernator, the hedgehog (Erinaceus europalus)
J. Lipid Res.
(1988)
Free and apo B-associated Lp a-specific protein in human serum
Clin. Chim. Acta
Lipoprotein Lp(a) is not a metabolic product of other lipoproteins containing apolipoprotein B
Biochim. Biophys. Acta
Rhesus monkey apolipoprotein (a) sequences, evolution and sites of synthesis
J. Biol. Chem.
Binding of Lp(a) to the low density lipoprotein receptor of human fibroblasts
FEBS Lett.
Uptake of Lp(a) lipoprotein by cultured fibroblasts
Biochem. Biophys. Res. Commun.
Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques
Lancet
Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study
Lancet
Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction
Lancet
Haemostatic factors in human aortic intima
Lancet
Effect of arterial proteoglycans on the interaction of LDL with human monocyte-derived macrophages
Arterosclerosis
Radioimmunoassay of human plasma Lp(a) lipoprotein
J. Lipid Res.
Lipoprotein Lp(a) and the risk for myocardial infarction
Atherosclerosis
Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction
Atherosclerosis
Serum lipids in angiographically assessed coronary atherosclerosis
Chest
The metabolism of very-low-density and intermediate-density lipoproteins in patients with familial hypercholesterolaemia
Atherosclerosis
A dominant role of lipoprotein (a) in the investigation and evaluation of parameters indicating the development of cervical atherosclerosis
Atherosclerosis
Hereditary and dietary effects on apolipoprotein (a) isoforms and Lp(a) in baboons
J. Lipid Res.
An isoprecipitation reaction distinguishing human serum-protein types
Lancet
A new serum type system in man — the LP-system
Acta Pathol. Microbiol. Scand.
Lp(a) lipoprotein/prebeta1-lipoprotein in Swedish middle-aged males and in patients with coronary heart disease
Clin. Genet.
“Sinking” prebetalipoprotein and the Lp antigen
Circulation
Protein and carbohydrate composition of Lp(a) lipoprotein from human plasma
Biochemistry
The Lp system
Ser. Haematol.
Studies of Lp(a)-lipoprotein as a quantitative genetic trait
The genetics of the LP antigen. II. A family study and proposed models of genetic control
Ann. Hum. Genet.
The genetics of quantitative plasma (Lp(a): analysis of a large pedigree
Am. J. Med. Genet.
Lipoprotein (a): biochemistry and biology
Studies of the structure of the Lp(a) lipoprotein: isolation and partial characterisation of the Lp(a) — specific antigen
Immunogenetics
Apolipoproteins and lipoproteins of human plasma. Significance in health and in disease
Adv. Lipid Res.
Lipoprotein Lp(a) in man: structure, metabolism and myocardial infarction risk
cDNA sequence of human apolipoprotein (a) is homologous to plasminogen
Nature
Partial amino acid sequence of apolipoprotein (a) shows that it is homologous to plasminogen
Lipoproteins and their metabolism
Lp(a) Lipoprotein as a risk factor for myocardial infarction
JAMA
Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography
Circulation
Sinking pre-beta lipoprotein and coronary heart disease in Japanese-American men in Hawaii
Am. J. Epidemiol.
Lipoprotein (a) as a strong indicator for cerebrovascular disease
Stroke
Twin studies of coronary heart disease and its risk factors
Acta Genet. Med. Gemellol. (Roma)
Genetics of lipoprotein disorders and coronary atheroma
Genetics of the quantitative Lp(a) lipoprotein trait III Contribution of Lp(a) glycoprotein phenotypes to normal lipid variation
Hum. Genet.
Cited by (235)
Administration of insulin like growth factor I (IGF[sbnd]I) lowers serum lipoprotein(a)-impact on atherosclerotic cardiovascular disease
2023, Growth Hormone and IGF ResearchLipoprotein(a), family history of cardiovascular disease, and incidence of heart failure
2023, Journal of Lipid ResearchIncrease of serum lipoprotein (a), an adverse effect of growth hormone treatment
2022, Growth Hormone and IGF ResearchCitation Excerpt :As a result, Lp(a) impedes that access of plasminogen to endothelial cell tissue. The induction by Lp(a) of plasminogen activator inhibitor-1 in endothelial cells could also contribute thrombogenesis [41]. It has been reported that a positive history of premature myocardial infarction is predicted by high serum Lp(a) [42,43].
The association between lipoprotein (a) and carotid atherosclerosis in patients with type 2 diabetes without pre-existing cardiovascular disease: A cross-sectional study
2021, Diabetes Research and Clinical PracticeCitation Excerpt :Lipoprotein (a) [Lp(a)] consists of apolipoprotein B-100 and apolipoprotein (a) [1], which has several pathogenic roles for atherosclerosis due to the similarity to low-density lipoprotein cholesterol (LDL-C) and thrombosis due to the similarity to plasminogen [2].
Impact of Lipoprotein(a) on Long-Term (Mean 6.2 Years) Outcomes in Patients With Three-Vessel Coronary Artery Disease
2020, American Journal of CardiologyLipoprotein(a) levels are associated with coronary severity but not with outcomes in Chinese patients underwent percutaneous coronary intervention
2020, Nutrition, Metabolism and Cardiovascular DiseasesCitation Excerpt :Lipoprotein(a) [Lp(a)] consists of apolipoprotein(a) and apolipoprotein B-100 and has a similar structure both to low-density lipoprotein (LDL) and to plasminogen [1,2].